1	In	in	_	_	_	_	_	_	_
2	vivo	vivo	_	_	_	_	_	_	_
3	anergized	anergize	_	_	_	_	_	_	_
4	CD4+	cd4+	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	express	express	_	_	_	_	_	_	_
8	perturbed	perturb	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factors	factor	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Anergy	Anergy	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	major	major	_	_	_	_	_	_	_
5	mechanism	mechanism	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	ensure	ensure	_	_	_	_	_	_	_
8	antigen-specific	antigen-specific	_	_	_	_	_	_	_
9	tolerance	tolerance	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	adult	adult	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vivo	vivo	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	anergy	anergy	_	_	_	_	_	_	_
5	has	have	_	_	_	_	_	_	_
6	mainly	mainly	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	studied	study	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	cellular	cellular	_	_	_	_	_	_	_
12	level	level	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	T-cell-activating	t-cell-activating	_	_	_	_	_	_	_
9	superantigen	superantigen	_	_	_	_	_	_	_
10	staphylococcal	staphylococcal	_	_	_	_	_	_	_
11	enterotoxin	enterotoxin	_	_	_	_	_	_	_
12	A	A	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	SEA	SEA	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	investigate	investigate	_	_	_	_	_	_	_
18	molecular	molecular	_	_	_	_	_	_	_
19	mechanisms	mechanism	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	T-lymphocyte	T-lymphocyte	_	_	_	_	_	_	_
22	anergy	anergy	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	vivo	vivo	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Injection	injection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	SEA	SEA	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	adult	adult	_	_	_	_	_	_	_
6	mice	mouse	_	_	_	_	_	_	_
7	activates	activate	_	_	_	_	_	_	_
8	CD4+	cd4+	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	expressing	express	_	_	_	_	_	_	_
12	certain	certain	_	_	_	_	_	_	_
13	T-cell	t-cell	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	TCR	TCR	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	variable	variable	_	_	_	_	_	_	_
19	region	region	_	_	_	_	_	_	_
20	beta-chain	beta-chain	_	_	_	_	_	_	_
21	families	family	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	induces	induce	_	_	_	_	_	_	_
24	strong	strong	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	rapid	rapid	_	_	_	_	_	_	_
27	production	production	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	interleukin	interleukin	_	_	_	_	_	_	_
30	2	2	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	IL-2	il-2	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	repeated	repeat	_	_	_	_	_	_	_
5	injections	injection	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	SEA	SEA	_	_	_	_	_	_	_
8	cause	cause	_	_	_	_	_	_	_
9	CD4+	cd4+	_	_	_	_	_	_	_
10	T-cell	t-cell	_	_	_	_	_	_	_
11	deletion	deletion	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	anergy	anergy	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	remaining	remain	_	_	_	_	_	_	_
17	CD4+	cd4+	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	characterized	characterize	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	reduced	reduce	_	_	_	_	_	_	_
24	expression	expression	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	IL-2	il-2	_	_	_	_	_	_	_
27	at	at	_	_	_	_	_	_	_
28	mRNA	mRNA	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	protein	protein	_	_	_	_	_	_	_
31	levels	level	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	analyzed	analyze	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	AP-1	ap-1	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	NF-AT	NF-AT	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	octamer	octamer	_	_	_	_	_	_	_
14	binding	binding	_	_	_	_	_	_	_
15	transcription	transcription	_	_	_	_	_	_	_
16	factors	factor	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	which	which	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	known	know	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	be	be	_	_	_	_	_	_	_
23	involved	involve	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	regulation	regulation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	gene	gene	_	_	_	_	_	_	_
30	promoter	promoter	_	_	_	_	_	_	_
31	activity	activity	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Large	large	_	_	_	_	_	_	_
2	amounts	amount	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	AP-1	AP-1	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	significant	significant	_	_	_	_	_	_	_
10	quantities	quantity	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NF-AT	NF-AT	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	SEA-activated	sea-activated	_	_	_	_	_	_	_
17	CD4+	cd4+	_	_	_	_	_	_	_
18	spleen	spleen	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	whereas	whereas	_	_	_	_	_	_	_
23	Oct-1	oct-1	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	Oct-2	oct-2	_	_	_	_	_	_	_
26	DNA	dna	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	activity	activity	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	similar	similar	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	both	both	_	_	_	_	_	_	_
33	resting	rest	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	activated	activate	_	_	_	_	_	_	_
36	T	t	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	anergic	anergic	_	_	_	_	_	_	_
5	CD4+	cd4+	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	contained	contain	_	_	_	_	_	_	_
9	severely	severely	_	_	_	_	_	_	_
10	reduced	reduce	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	AP-1	ap-1	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Fos/Jun-containing	fos/jun-containing	_	_	_	_	_	_	_
16	NF-AT	NF-AT	_	_	_	_	_	_	_
17	complexes	complex	_	_	_	_	_	_	_
18	but	but	_	_	_	_	_	_	_
19	expressed	express	_	_	_	_	_	_	_
20	significant	significant	_	_	_	_	_	_	_
21	amounts	amount	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	Oct	Oct	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	proteins	protein	_	_	_	_	_	_	_
29	after	after	_	_	_	_	_	_	_
30	SEA	SEA	_	_	_	_	_	_	_
31	stimulation	stimulation	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Resolution	Resolution	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	complex	complex	_	_	_	_	_	_	_
7	demonstrated	demonstrate	_	_	_	_	_	_	_
8	predominant	predominant	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	p50-p65	p50-p65	_	_	_	_	_	_	_
12	heterodimers	heterodimer	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	CD4+	cd4+	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	while	while	_	_	_	_	_	_	_
20	anergic	anergic	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	mainly	mainly	_	_	_	_	_	_	_
23	expressed	express	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	transcriptionally	transcriptionally	_	_	_	_	_	_	_
26	inactive	inactive	_	_	_	_	_	_	_
27	p50	p50	_	_	_	_	_	_	_
28	homodimer	homodimer	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	alterations	alteration	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	factors	factor	_	_	_	_	_	_	_
6	are	be	_	_	_	_	_	_	_
7	likely	likely	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	be	be	_	_	_	_	_	_	_
10	responsible	responsible	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	repression	repression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	anergic	anergic	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

